City
Mauston Area Ambulance
Drugs and doses50
A–C Acetaminophen, Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Calcium Chloride, Cefazolin, Clopidogrel9
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 500 mg | PO | not captured | standing | page 27 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 59 |
| Narrow-complex tachycardia | adult | 6 mg | IV | not captured | standing | pages 18, 59 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg | IV | not captured | standing | pages 18, 59 |
| Wide-complex tachycardia | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 60 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2.5 mg | NEB | not captured | standing | page 9 |
| Other | peds | 2.5 mg | NEB | not captured | standing | page 55 |
| Other | peds | 2.5 mg | NEB | not captured | standing | page 61 |
| Respiratory distress | adult | 2.5 mg | NEB | not captured | standing | pages 9, 53, 55, 61 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 300 mg | IV/IO | not captured | standing | pages 15, 16 |
| Cardiac arrest | peds | 5 mg/kg | IV/IO | not captured | standing | pages 15, 16 |
| Other | adult | 150 mg | IV/IO | not captured | standing | page 20 |
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | pages 20, 21, 60 |
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | pages 21, 60 |
| Wide-complex tachycardia | peds | 5 mg/kg | IV/IO | not captured | standing | pages 20, 21, 60 |
| Wide-complex tachycardia | peds | 5 mg/kg | IV/IO | not captured | standing | pages 21, 60 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | pages 10, 13 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | pages 17, 58 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 17, 58 |
| Other | adult | 2 mg | IV | not captured | standing | pages 34, 67 |
| Other | peds | 0.02 mg/kg | IV | not captured | standing | pages 34, 67 |
| Other | peds | 0.02 mg/kg | IV | not captured | standing | page 58 |
| Other | peds | 0.02 mg/kg | IV/IM | not captured | standing | page 67 |
| RSI induction | peds | 0.01–0.02 mg/kg | IV/IO | not captured | standing | page 12 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 500–1000 mg | IV/IO | not captured | standing | pages 16, 17, 32 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 500 mg | IV/IO | not captured | standing | pages 16, 17, 32 |
| Hyperkalemia | adult | 500–1000 mg | IV/IO | not captured | standing | pages 16, 17 |
| Other | adult | 1 g | IV/IO | not captured | standing | page 49 |
| Other | adult | 500 mg | IV | not captured | standing | page 32 |
| Other | adult | 500–1000 mg | IV/IO | not captured | standing | page 16 |
Cefazolin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 2 g | IV/IO/IM | not captured | standing | page 49 |
Clopidogrel
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 75 mg | PO | not captured | standing | page 81 |
D–F Dextrose, Diazepam, Diltiazem, Diphenhydramine, Dopamine, Droperidol, Epinephrine, Etomidate, Fentanyl9
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | peds | 0.2 g/kg | IV | not captured | standing | pages 33, 45 |
| Other | peds | 0.2 g/kg | IV/IO | not captured | standing | page 45 |
| Other | peds | 500 mg/kg | IV/IO | not captured | standing | page 63 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 5–10 mg | IM/PR | not captured | standing | page 28 |
| Other | peds | 0.3 mg/kg | IV/IO | not captured | standing | page 62 |
| Seizure | adult | 5–10 mg | IV/IO/IM/PR | not captured | standing | page 29 |
| Seizure | peds | 0.3 mg/kg | PR | not captured | standing | page 62 |
| Seizure | peds | 0.3 mg/kg | IV/IO/IM/PR | not captured | standing | page 29 |
| Seizure | peds | 0.5 mg/kg | PR | not captured | standing | page 62 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 5 mg | not captured | not captured | standing | page 19 |
| Narrow-complex tachycardia | adult | 0.25 mg/kg | IV/IO | not captured | standing | pages 18, 19 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 25–50 mg | IV/IO | not captured | standing | pages 22, 61 |
| Anaphylaxis | adult | 50 mg | IM | not captured | standing | pages 22, 61 |
| Anaphylaxis | peds | 1 mg/kg | IV/IO | not captured | standing | pages 22, 61 |
| Anaphylaxis | peds | 1 mg/kg | IM | not captured | standing | pages 22, 61 |
| Nausea / vomiting | adult | 25–50 mg | IV | not captured | standing | page 38 |
| Other | adult | 25–50 mg | IV | not captured | standing | page 28 |
| Other | peds | 1 mg/kg | IV/IM | not captured | standing | page 61 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2–20 mcg/kg | IV | not captured | standing | page 159 |
Droperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2.5 mg | IV | not captured | standing | page 28 |
| Other | adult | 5 mg | IM | not captured | standing | page 28 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3–0.5 mg | IM | not captured | standing | pages 22, 61 |
| Anaphylaxis | adult | 0.3–0.5 mg | IM | not captured | standing | page 22 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | pages 22, 61 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | page 22 |
| Asthma / bronchospasm | adult | 0.3–0.5 mg | IM | not captured | standing | pages 9, 55 |
| Asthma / bronchospasm | peds | 0.01 mg/kg | IM | not captured | standing | pages 9, 55 |
| Bradycardia | adult | 2–10 mcg | IV/IO | not captured | standing | page 17 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 58 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 15, 16, 56, 57 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 15, 16, 56, 57 |
| Croup | peds | 1 mg | NEB | not captured | standing | pages 7, 53 |
| Other | peds | 0.01 mg/kg | IM | not captured | standing | page 61 |
| Other | peds | 0.15 mg | IM | not captured | standing | page 61 |
| Other | peds | 0.3 mg | IM | not captured | standing | page 61 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.3–0.6 mg/kg | IV | not captured | standing | page 12 |
| RSI induction | adult | 0.3–0.6 mg/kg | IV/IO | not captured | standing | pages 11, 12 |
| RSI induction | peds | 0.3–0.6 mg/kg | IV/IO | not captured | standing | pages 11, 12 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 25–50 mcg | IV | not captured | standing | page 84 |
| Other | adult | 25–100 mcg | IV | not captured | standing | page 13 |
| Mild to moderate pain | adult | 25–100 mcg | IV/IO/IM/IN | not captured | standing | pages 13, 27 |
| RSI induction | adult | 100 mcg | IV/IO | not captured | standing | page 11 |
| RSI induction | adult | 100 mcg | IV/IO | not captured | standing | page 12 |
| RSI induction | peds | 1–1.5 mcg/kg | IV/IO | not captured | standing | page 11 |
| RSI induction | peds | 1–1.5 mcg/kg | IV/IO | not captured | standing | page 12 |
G–L Glucagon, Haloperidol, Hydromorphone, Ipratropium, Ketamine, Ketorolac, Labetalol, Lidocaine, Lorazepam9
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1–2 mg | IV/IO | not captured | standing | pages 9, 32, 67 |
| Bradycardia | adult | 2–5 mg | IV | not captured | standing | page 17 |
| Other | adult | 1 mg | IM | not captured | standing | pages 33, 63 |
| Other | peds | 0.5 mg | IM | not captured | standing | pages 33, 63 |
| Other | peds | 1 mg | IM | not captured | standing | page 63 |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2–5 mg | IM | not captured | standing | page 28 |
Hydromorphone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | peds | 0.015 mg/kg | not captured | not captured | standing | page 27 |
| Mild to moderate pain | adult | 0.5–2 mg | IV/IO/IM | not captured | standing | page 27 |
| Mild to moderate pain | peds | 0.015 mg/kg | IV/IO/IM | not captured | standing | page 27 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | pages 9, 55, 61 |
| Other | adult | 0.5 mg | NEB | not captured | standing | page 9 |
| Other | peds | 0.5 mg | NEB | not captured | standing | page 55 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5–2 mg/kg | IV/IO | not captured | standing | page 28 |
| Other | adult | 2–4 mg/kg | IM | not captured | standing | page 28 |
| Mild to moderate pain | adult | 0.3 mg/kg | IV/IO/IM/IN | not captured | standing | page 27 |
| Mild to moderate pain | adult | 0.3 mg/kg | IV/IO/IM/IN | not captured | standing | page 27 |
| Mild to moderate pain | peds | 0.3 mg/kg | IV/IO/IM/IN | not captured | standing | page 27 |
| RSI induction | adult | 1–2 mg/kg | IV | not captured | standing | page 12 |
| RSI induction | adult | 2 mg/kg | IV/IO | not captured | standing | pages 11, 12 |
| RSI induction | peds | 2 mg/kg | IV/IO | not captured | standing | pages 11, 12 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 15 mg | IV | not captured | standing | page 27 |
| Mild to moderate pain | adult | 30 mg | IM | not captured | standing | page 27 |
| Mild to moderate pain | peds | 0.5 mg/kg | IV | not captured | standing | page 27 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 20 mg | IV | not captured | standing | page 36 |
| Other | adult | 20 mg | IV | not captured | standing | page 36 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | pages 15, 16, 57 |
| Cardiac arrest | peds | 1 mg/kg | IV/IO | not captured | standing | pages 15, 16, 57 |
| Other | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | page 20 |
| Other | adult | 40 mg | IO | not captured | standing | page 143 |
| Other | peds | 0.5 mg/kg | IO | not captured | standing | page 143 |
| Mild to moderate pain | adult | 40 mg | IO | not captured | standing | page 143 |
| Mild to moderate pain | peds | 0.5 mg/kg | IO | not captured | standing | page 143 |
| Wide-complex tachycardia | adult | 0.5–0.75 mg/kg | IV/IO | not captured | standing | pages 21, 60 |
| Wide-complex tachycardia | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | pages 20, 21, 60 |
| Wide-complex tachycardia | peds | 1 mg/kg | IV/IO | not captured | standing | pages 20, 21, 60 |
| Wide-complex tachycardia | peds | 1 mg/kg | IV/IO | not captured | standing | pages 21, 60 |
| VF / pulseless VT | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | pages 15, 57 |
| VF / pulseless VT | peds | 1 mg/kg | IV/IO | not captured | standing | pages 15, 57 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–2 mg | IV/IN | not captured | standing | page 28 |
| Other | adult | 2–4 mg | IM/PR | not captured | standing | page 28 |
| Other | peds | 0.1 mg/kg | IM/IN/PR | not captured | standing | page 62 |
| Seizure | adult | 2 mg | IV/IO | not captured | standing | pages 29, 62 |
| Seizure | adult | 2 mg | IM/IN | not captured | standing | pages 29, 62 |
| Seizure | adult | 2–4 mg | PR | not captured | standing | pages 29, 62 |
| Seizure | adult | 2 mg | IV/IO/IM/IN | not captured | standing | page 29 |
| Seizure | peds | 0.05–0.1 mg/kg | IV/IO | not captured | standing | pages 29, 62 |
| Seizure | peds | 0.1 mg/kg | IM/IN | not captured | standing | pages 29, 62 |
| Seizure | peds | 0.1 mg/kg | PR | not captured | standing | pages 29, 62 |
M–O Magnesium Sulfate, Methylprednisolone, Metoclopramide, Metoprolol, Midazolam, Morphine, Naloxone, Nitroglycerin, Norepinephrine, Ondansetron, Oral Glucose11
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 1–2 g | IV/IO | not captured | standing | pages 9, 55, 61 |
| Asthma / bronchospasm | peds | 50 mg/kg | IV/IO | not captured | standing | pages 9, 55, 61 |
| Other | adult | 2 g | IV | not captured | standing | page 22 |
| Other | adult | 4 g | IV | not captured | standing | page 46 |
| Other | adult | 5 g | IM | not captured | standing | page 46 |
| Other | peds | 50 mg/kg | IV | not captured | standing | page 55 |
| VF / pulseless VT | adult | 2 g | IV/IO | not captured | standing | pages 16, 21, 57 |
| VF / pulseless VT | peds | 50 mg/kg | IV/IO | not captured | standing | pages 16, 21, 57 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 125 mg | IV/IO | not captured | standing | pages 22, 61 |
| Anaphylaxis | peds | 2 mg/kg | IV/IO | not captured | standing | pages 22, 61 |
| Other | adult | 125 mg | IV/IO/IM | not captured | standing | pages 9, 55 |
| Other | peds | 2 mg/kg | IV/IO/IM | not captured | standing | pages 9, 55 |
Metoclopramide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 5–10 mg | IV/IM | not captured | standing | page 38 |
Metoprolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 5 mg | IV | not captured | standing | page 36 |
| Narrow-complex tachycardia | adult | 5 mg | IV | not captured | standing | page 19 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–2 mg | IV | not captured | standing | page 28 |
| Other | adult | 1–5 mg | IV/IN | not captured | standing | page 28 |
| Other | adult | 2–10 mg | IM | not captured | standing | page 28 |
| Other | peds | 0.1 mg/kg | IV/IO/IM/IN/PR | not captured | standing | page 62 |
| RSI induction | adult | 5–10 mg | IV/IO | not captured | standing | page 11 |
| RSI induction | adult | 5–10 mg | IV/IO | not captured | standing | page 12 |
| Seizure | adult | 5 mg | IM | not captured | standing | page 29 |
| Seizure | adult | 5 mg | PR | not captured | standing | page 29 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 1–6 mg | IV/IO/IM | not captured | standing | page 27 |
| Mild to moderate pain | adult | 1–6 mg | IV/IO/IM | not captured | standing | page 27 |
| Mild to moderate pain | peds | 0.05–0.1 mg/kg | IV/IO/IM | not captured | standing | page 27 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4 mg | IN | not captured | standing | page 31 |
| Opioid overdose | adult | 0.4 mg | IM/IN | not captured | standing | page 31 |
| Opioid overdose | adult | 0.4 mg | IV/IM/IN | not captured | standing | page 31 |
| Opioid overdose | peds | 0.1 mg/kg | IM | not captured | standing | page 66 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 66 |
| Opioid overdose | peds | 0.4–2 mg | IM | not captured | standing | page 66 |
| Opioid overdose | peds | 0.4–2 mg | IV/IO | not captured | standing | page 66 |
| Opioid overdose | peds | 0.5 mg | IV/IO | not captured | standing | page 45 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.4 mg | SL | not captured | standing | pages 10, 13 |
| Other | adult | 0.4 mg | SL | not captured | standing | page 10 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.05–0.3 mcg/kg | IV/IO | not captured | standing | page 84 |
| Other | adult | 2 mcg | IV/IO | not captured | standing | page 159 |
| Other | adult | 2–20 mcg | IV/IO | not captured | standing | page 84 |
| Other | adult | 2–20 mcg | IV | not captured | standing | pages 37, 159 |
| Other | adult | 2–20 mcg | IV/IO | not captured | standing | page 37 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | peds | 2 mg | IV/IM/PO | not captured | standing | page 38 |
| Other | adult | 4 mg | IV/IM | not captured | standing | page 38 |
| Other | adult | 4 mg | IV/IM/PO | not captured | standing | page 38 |
| Other | peds | 2 mg | IV/IM | not captured | standing | page 38 |
| Other | peds | 4 mg | IV/IM/PO | not captured | standing | page 38 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 15 g | PO | not captured | standing | page 46 |
| Other | adult | 15–25 g | PO | not captured | standing | pages 33, 46 |
| Other | adult | 15–25 g | PO | not captured | standing | page 33 |
| Other | peds | 15 g | PO | not captured | standing | pages 33, 46 |
| Other | peds | 15 g | PO | not captured | standing | page 63 |
P–R Phenylephrine, Plasma, Prochlorperazine, Promethazine, Propofol, Rocuronium6
Phenylephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 100–200 mcg | IV | not captured | standing | page 37 |
| Other | adult | 100–200 mcg | IV/IO | not captured | standing | page 37 |
Plasma
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | peds | 10 mL/kg | IV/IO | not captured | standing | page 49 |
| Trauma / hemorrhage | adult | 1–2 unit | IV/IO | not captured | standing | page 49 |
| Trauma / hemorrhage | peds | 10 mL/kg | IV/IO | not captured | standing | page 49 |
Prochlorperazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 5–10 mg | IV/IM | not captured | standing | page 38 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 12.5–25 mg | IV | not captured | standing | page 38 |
Propofol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.1–0.5 mg/kg | IV | not captured | standing | page 165 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1 mg/kg | IV | not captured | standing | page 11 |
| RSI induction | adult | 1 mg/kg | IV | not captured | standing | page 12 |
| RSI induction | peds | 1 mg/kg | IV | not captured | standing | page 11 |
| RSI induction | peds | 1 mg/kg | IV | not captured | standing | page 12 |
S–Z Sodium Bicarbonate, Tranexamic Acid, Vasopressin, Vecuronium, Whole Blood, Ziprasidone6
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 50 mEq | IV/IO | not captured | standing | pages 16, 57 |
| Cardiac arrest | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 16, 57 |
| Crush injury | adult | 50 mEq | IV/IO | not captured | standing | page 52 |
| Crush injury | adult | 50 mEq | IV/IO | not captured | standing | page 52 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | page 32 |
| Other | adult | 1 mEq/kg | IV | not captured | standing | pages 32, 67 |
| Other | adult | 50 mEq | IV/IO | not captured | standing | page 16 |
| Other | adult | 50 mEq | IV | not captured | standing | page 84 |
| Other | peds | 1 mEq/kg | IV | not captured | standing | pages 32, 67 |
| Tricyclic overdose | adult | 1 mEq/kg | IV | not captured | standing | pages 32, 67 |
| Tricyclic overdose | peds | 1 mEq/kg | IV | not captured | standing | pages 32, 67 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1000 mg | IV/IO | not captured | standing | page 49 |
| Trauma / hemorrhage | adult | 1000 mg | IV/IO | not captured | standing | page 49 |
Vasopressin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 40 unit | IV/IO | not captured | standing | pages 15, 16 |
Vecuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 5–10 mg | IV | not captured | standing | page 11 |
| RSI induction | adult | 5–10 mg | IV | not captured | standing | page 12 |
Whole Blood
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | peds | 10 mL/kg | IV/IO | not captured | standing | page 49 |
| Trauma / hemorrhage | adult | 1–3 unit | IV/IO | not captured | standing | page 49 |
| Trauma / hemorrhage | peds | 10 mL/kg | IV/IO | not captured | standing | page 49 |
Ziprasidone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10–20 mg | IM | not captured | standing | page 28 |
Cite this
Mauston Area Ambulance, United States EMS Protocol Census. 208 dose entries, effective 2025-09-01.
https://protoquiz.com/census/agencies/mauston-area-ambulance/
The census is free and not for sale. Only public agencies are named.